10,831 Shares in Vital Farms, Inc. (NASDAQ:VITL) Purchased by Centiva Capital LP

Centiva Capital LP acquired a new position in Vital Farms, Inc. (NASDAQ:VITL) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,831 shares of the company’s stock, valued at approximately $408,000.

Several other large investors also recently bought and sold shares of the company. Barclays PLC boosted its stake in shares of Vital Farms by 57.3% in the third quarter. Barclays PLC now owns 95,444 shares of the company’s stock worth $3,347,000 after acquiring an additional 34,758 shares during the last quarter. Franklin Resources Inc. boosted its stake in Vital Farms by 10.2% during the 3rd quarter. Franklin Resources Inc. now owns 372,583 shares of the company’s stock worth $13,066,000 after purchasing an additional 34,412 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Vital Farms by 35.6% during the third quarter. Principal Financial Group Inc. now owns 655,811 shares of the company’s stock worth $22,999,000 after buying an additional 172,249 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Vital Farms by 38.9% in the third quarter. JPMorgan Chase & Co. now owns 266,398 shares of the company’s stock worth $9,343,000 after buying an additional 74,593 shares in the last quarter. Finally, Nordea Investment Management AB purchased a new position in shares of Vital Farms in the fourth quarter worth about $2,765,000. 98.59% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Russell Diez-Canseco sold 45,124 shares of Vital Farms stock in a transaction on Monday, April 14th. The stock was sold at an average price of $33.69, for a total value of $1,520,227.56. Following the completion of the transaction, the chief executive officer now directly owns 703,736 shares in the company, valued at approximately $23,708,865.84. This trade represents a 6.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Matthew Ohayer sold 4,000 shares of the company’s stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $31.39, for a total value of $125,560.00. Following the sale, the insider now owns 6,966,890 shares in the company, valued at approximately $218,690,677.10. This trade represents a 0.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 93,124 shares of company stock worth $3,019,308 over the last three months. Company insiders own 27.60% of the company’s stock.

Vital Farms Price Performance

Vital Farms stock opened at $33.82 on Friday. The company’s 50 day simple moving average is $32.50 and its 200-day simple moving average is $35.06. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. Vital Farms, Inc. has a 1 year low of $27.91 and a 1 year high of $48.41. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of 30.20 and a beta of 0.94.

Vital Farms (NASDAQ:VITL) last announced its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.11. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company had revenue of $162.19 million for the quarter, compared to analyst estimates of $164.43 million. During the same quarter in the previous year, the company earned $0.43 earnings per share. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. As a group, equities research analysts expect that Vital Farms, Inc. will post 1.11 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. William Blair reiterated an “outperform” rating on shares of Vital Farms in a report on Friday, February 28th. DA Davidson reduced their price objective on Vital Farms from $44.00 to $42.00 and set a “buy” rating on the stock in a research report on Friday, March 14th. BMO Capital Markets upgraded Vital Farms to a “strong-buy” rating in a report on Tuesday, May 6th. Morgan Stanley reduced their price target on Vital Farms from $40.00 to $39.00 and set an “overweight” rating on the stock in a report on Thursday, April 17th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $52.00 price objective on shares of Vital Farms in a research report on Monday, May 5th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Vital Farms presently has a consensus rating of “Buy” and an average target price of $44.63.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.